Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Feb 25, 2024 9:16pm
98 Views
Post# 35898300

RE:There is

RE:There isCouple of options:
Do a 4:1 split so the little people i.e. retail investors can get in on the action at an attractive 1 cent per share, tell their mothers they are big time shareholders like jb nb goj with hundreds of shares;
Do a another reverse split 8: 1 to get us to 32 cents.
Having trouble figuring out which is the optimal
IainCaimbeul wrote: a prediction on the CEO board of 1 cent share value coming, any takers?

Several years ago Tripp and the pumpers were seriously talking about the nasdag. When i ridiculed the ridulouse I was pounced on by the ridiculous pumpers.
P.S. a few years back one of the trippingxxx basher said the stock was going to 10 cents. Well he was incorrect; 4 cents.
<< Previous
Bullboard Posts
Next >>